Dr. Leblanc is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3333 Burnet Ave # MLC5018
Cincinnati, OH 45229Phone+1 513-636-4315
Summary
- I am a Pediatric Hematology and Oncology clinical fellow at the Cancer and Blood Diseases Institute at the Cincinnati Children’s Hospital Medical Center. I completed my Pediatrics training through the Accelerated Research Pathway at Cincinnati Children’s. I am currently the recipient of an NIH K12 grant through the Pediatric Scientist Development Program and am actively researching Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) in the laboratory of Dr. Daniel. Starczynowski.
My clinical interests are directed towards relapsed and refractory AML and developing novel therapeutic approaches supported by our work in the laboratory.
My long-term research interests involve the development of a deeper understanding of the complex molecular, cellular, genetic and epigenetic underpinnings of hematological malignancies. My overall short-term goal is to identify novel therapeutic targets in MDS/AML ultimately translating these into clinical application for treatment of an otherwise devastating childhood disease.
Education & Training
- Cincinnati Children's Hospital Medical CenterFellowship, Pediatric Hematology/Oncology, 2020
- Cincinnati Children's Hospital Medical CenterResidency, Pediatrics, 2018 - 2020
- Pennsylvania State University College of MedicineClass of 2018, MD, PhD, Judith Bond MD/PhD Award
- Penn State College of MedicinePhD, Molecular Medicine, 2011 - 2016
Certifications & Licensure
- OH State Medical License 2018 - 2025
- American Board of Pediatrics Pediatrics
Publications & Presentations
PubMed
- 298 citationsSTAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemiaAndres Jerez, Michael J. Clemente, Hideki Makishima, Hanna Koskela, Francis R LeBlanc
Blood. 2012-10-11 - Combined epigenetic and immunotherapy for blastic and classical mantle cell lymphoma.Francis R LeBlanc, Zainul S Hasanali, August Stuart, Sara Shimko, Kamal Sharma
Oncotarget. 2022-01-01 - 29 citationsLarge granular lymphocyte leukemia: from dysregulated pathways to therapeutic targets.Francis R LeBlanc, Dan Zhang, Xin Liu, Thomas P. Loughran
Future Oncology. 2012-07-25
Grant Support
- Pediatric Scientist Development Program - NIH K12NIH - Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)2021–2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: